Track the latest insights on ampicillin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Get real-time access to monthly/quarterly/yearly prices Request Sample
During the fourth quarter of 2025, the ampicillin prices in Japan reached 35.4 USD/KG in December. Prices rose, supported by steady demand from pharmaceutical formulation companies and hospital procurement programs. Additionally, consistent purchasing from antibiotic drug manufacturers sustained regular production planning. Suppliers maintained disciplined manufacturing schedules while distributors ensured stable supply across pharmaceutical supply chains.
During the fourth quarter of 2025, the ampicillin prices in China reached 31.1 USD/KG in December. Prices increased, driven by consistent demand from pharmaceutical manufacturers producing antibacterial medications. Moreover, export-oriented procurement from regional drug producers supported active market participation. Manufacturers maintained structured production planning while distributors aligned supply with downstream formulation activity.
During the fourth quarter of 2025, the ampicillin prices in Vietnam reached 31.0 USD/KG in December. Prices moved upward, influenced by firm demand from pharmaceutical processing facilities and hospital supply networks. Furthermore, procurement from antibiotic formulation manufacturers supported stable trading activity. Organized distribution channels ensured reliable supply across pharmaceutical production hubs.
During the fourth quarter of 2025, the ampicillin prices in South Korea reached 31.8 USD/KG in December. Prices climbed, supported by steady demand from pharmaceutical ingredient processors and healthcare product manufacturers. Additionally, procurement from antibiotic drug production units remained stable. Producers maintained balanced output levels while distributors supplied volumes aligned with pharmaceutical industry requirements.
During the fourth quarter of 2025, the ampicillin prices in Thailand reached 30.8 USD/KG in December. Prices edged higher, driven by consistent demand from pharmaceutical formulation companies and hospital procurement systems. In addition to this, regional drug manufacturers maintained regular purchasing cycles. Distributors managed balanced inventories to support steady pharmaceutical production.
During the third quarter of 2025, the ampicillin prices in Japan reached 34.7 USD/KG in September. Prices rose, supported by steady procurement from pharmaceutical manufacturers producing antibacterial formulations. Additionally, hospital purchasing programs maintained consistent demand across healthcare supply chains. Producers maintained stable production schedules while distributors ensured reliable supply to drug manufacturers.
During the third quarter of 2025, the ampicillin prices in China reached 30.8 USD/KG in September. Prices increased, driven by active demand from pharmaceutical formulation units and export-oriented antibiotic manufacturers. Moreover, procurement from regional healthcare markets supported steady purchasing cycles. Manufacturers aligned production with ongoing pharmaceutical processing requirements.
During the third quarter of 2025, the ampicillin prices in Vietnam reached 29.8 USD/KG in September. Prices moved upward, influenced by stable demand from pharmaceutical ingredient processors and drug manufacturing companies. Furthermore, procurement from hospital supply programs supported consistent trading activity. Distributors maintained organized supply chains across healthcare markets.
During the third quarter of 2025, the ampicillin prices in South Korea reached 30.5 USD/KG in September. Prices climbed, supported by steady demand from pharmaceutical manufacturers and healthcare product producers. Additionally, procurement from antibiotic formulation units remained active. Suppliers maintained stable output while distributors ensured reliable product availability.
During the third quarter of 2025, the ampicillin prices in Thailand reached 30.0 USD/KG in September. Prices edged higher, driven by consistent procurement from pharmaceutical formulation facilities and healthcare distribution networks. In addition to this, steady purchasing from regional drug manufacturers supported organized supply conditions. Buyers maintained regular procurement cycles aligned with pharmaceutical production schedules.
During the second quarter of 2025, the ampicillin prices in Japan reached 35.1 USD/Kg in June. In Q2 2025, ampicillin prices in Japan were influenced by sustained procurement from the pharmaceutical manufacturing sector ahead of the summer flu season. Import dependency on active pharmaceutical ingredients (APIs) from China led to cost fluctuations amid periodic supply delays. Additionally, regulatory audits on antimicrobial stewardship in hospitals increased demand for narrow-spectrum antibiotics, indirectly supporting stable purchase volumes. The depreciation of the yen against the US dollar further impacted import-related cost structures.
During the second quarter of 2025, ampicillin prices in China reached 31.7 USD/Kg in June. Ampicillin prices in China during Q2 2025 were primarily affected by environmental compliance inspections across key antibiotic production hubs in Zhejiang and Shandong provinces, which led to temporary operational suspensions. Feedstock availability for 6-APA remained inconsistent due to limited fermentation batch yields, impacting supply. Simultaneously, the demand from both domestic pharmaceutical firms and international buyers remained steady, driven by restocking needs and export contracts under fixed-delivery terms.
During the second quarter of 2025, the ampicillin prices in Vietnam reached 30.6 USD/Kg in June. In Q2 2025, Vietnam’s ampicillin prices were shaped by robust demand from the public healthcare sector, following increased government procurement for rural health centers. Delays in customs clearance for API imports from China disrupted formulation schedules, creating supply tightness. Additionally, localized production challenges, including limited fermentation capacity and higher energy costs, constrained domestic output. Currency depreciation also played a role in raising the overall landed cost of imported formulations.
During the second quarter of 2025, the ampicillin prices in South Korea reached 29.5 USD/Kg in June. Ampicillin prices in South Korea were influenced by elevated procurement from the pharmaceutical formulation sector, particularly driven by seasonal illnesses and hospital inventory replenishments. The market also experienced price sensitivity due to delays in shipments from Chinese API suppliers. Rising compliance costs related to new Good Manufacturing Practice (GMP) revisions added further cost pressures for local manufacturers. Strategic stockpiling by wholesalers in anticipation of future demand fluctuations contributed to short-term demand surges.
During the second quarter of 2025, the ampicillin prices in Thailand reached 30.6 USD/Kg in June. In Q2 2025, ampicillin prices in Thailand were impacted by a combination of steady demand from the public health sector and supply-side challenges related to API imports. Port congestion and adverse weather conditions disrupted delivery schedules from key Chinese suppliers. Domestic manufacturers faced increased operational costs due to higher fermentation media prices. Moreover, the introduction of revised procurement policies under the national drug budget led to competitive bulk buying, influencing short-term market dynamics.
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the ampicillin prices.
Q4 2025:
As per the ampicillin price index, Europe reflected procurement activity across regulated pharmaceutical manufacturing networks. Antibiotic formulation companies continued sourcing active pharmaceutical ingredients to support ongoing drug production. Moreover, hospital procurement systems and national healthcare supply programs sustained purchasing activity. Regulatory compliance requirements and structured pharmaceutical distribution networks continued to shape supply planning across the region.
Q3 2025:
European prices were influenced by demand from pharmaceutical formulation manufacturers and medical treatment programs. Antibiotic producers maintained procurement of active pharmaceutical ingredients for prescription drug manufacturing. Moreover, hospital purchasing frameworks and public healthcare supply systems continued sourcing materials for medical distribution networks across the region.
Q2 2025:
As per the ampicillin price index, the European market maintained high price levels due to finite supplies. Production output was hampered by maintenance plans at refineries. Overall consumption did not significantly increase in spite of these supply-side issues, especially in the agricultural input segment. The market remained solid due to stable usage and limited availability. As a result, sustained supply pressures and steady downstream demands supported the ampicillin market's steady trajectory throughout the time frame.
This analysis can be extended to include detailed ampicillin price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q4 2025:
As per the ampicillin price index, North America reflected ongoing activity within pharmaceutical production and healthcare distribution channels. Antibiotic manufacturing facilities continued sourcing raw materials to support prescription drug formulation. Furthermore, healthcare distributors and hospital procurement systems maintained purchasing cycles aligned with treatment demand. Established pharmaceutical logistics networks and regulatory supply frameworks continued to guide product movement across the market.
Q3 2025:
North American prices were influenced by procurement within pharmaceutical supply chains supporting antibiotic drug production. Pharmaceutical companies continued sourcing materials for formulation activities while healthcare distributors ensured product movement to hospitals and pharmacies. Additionally, structured regulatory oversight and established pharmaceutical logistics systems supported ongoing distribution across healthcare markets.
Q2 2025:
As per the ampicillin price index, in North America, the market was in a balanced state during the second quarter of 2025. Due to high refinery operating rates, major producing regions such as the Midwest and Gulf Coast reported steady output. However, seasonal variations, especially unfavorable winter conditions, created intermittent logistical challenges. The agricultural chemical segment's demand remained stable, and despite concerns about potential tariff effects, there were no significant price changes. There was little price fluctuation throughout the quarter, and the regional market remained stable in terms of supply and demand dynamics.
Specific ampicillin historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Q4 2025:
As per ampicillin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q3 2025:
The report explores the ampicillin pricing trends and ampicillin price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.
In addition to region-wise data, information on ampicillin prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q4 2025:
Prices rose, supported by strong demand from pharmaceutical manufacturing hubs and antibiotic formulation facilities. Regional drug producers maintained active procurement of active pharmaceutical ingredients to support antibacterial drug production. Moreover, hospital procurement programs and expanding healthcare consumption sustained purchasing activity. Organized domestic production capacity and regional pharmaceutical trade networks supported consistent supply to formulation companies.
Q3 2025:
In the Asia Pacific region, prices edged higher, influenced by procurement from pharmaceutical formulation companies and antibiotic drug manufacturers. Pharmaceutical producers continued sourcing active pharmaceutical ingredients to support prescription drug manufacturing programs. Furthermore, healthcare distribution networks and hospital purchasing systems maintained regular procurement cycles. Regional pharmaceutical manufacturing clusters and established export channels supported ongoing supply movement across drug production markets.
Q2 2025:
In Q2 2025, ampicillin prices in the Asia Pacific region were influenced by a convergence of supply chain constraints and consistent regional demand. Periodic environmental audits in China disrupted the production of key intermediates such as 6-APA, affecting export volumes to formulation hubs across Southeast Asia. The pharmaceutical manufacturing sector in India, Vietnam, and Indonesia registered increased procurement due to public health initiatives and seasonal infection cycles. Logistical disruptions from port congestion and currency fluctuations across emerging economies further contributed to cost variations. Additionally, regulatory scrutiny on antimicrobial usage supported procurement of narrow-spectrum antibiotics, impacting sourcing strategies and purchase volumes.
This ampicillin price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q4 2025:
Latin America's ampicillin market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in ampicillin prices.
Q3 2025:
Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting Latin America’s ability to meet international demand consistently. Moreover, the ampicillin price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing ampicillin pricing trends in this region.
Q2 2025:
Latin America's ampicillin market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in ampicillin prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the ampicillin price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing ampicillin pricing trends in this region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Ampicillin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the ampicillin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ampicillin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ampicillin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ampicillin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

The global ampicillin industry size reached USD 189.6 Million in 2025. By 2034, IMARC Group expects the market to reach USD 244.8 Million, at a projected CAGR of 2.76% during 2026-2034. Growth is driven by increasing demand for broad-spectrum antibiotics in human healthcare, expanding pharmaceutical manufacturing capacity, and rising healthcare access across emerging economies. Additionally, consistent demand from hospital treatment programs and pharmaceutical formulations continues to support steady industry expansion.
Latest News and Developments:
Ampicillin refers to a semi-synthetic derivative of penicillin, improvised to enhance its efficacy in comparison to a wide array of bacterial infections. It is a broad-spectrum, antibiotic which is used to manage numerous bacterial infections by restricting the synthesis of bacterial cell walls thereby leading to the lysis and death of the bacteria. The product has been proven effective against both Gram-positive and Gram-negative bacteria, making it a popular choice for veterinary, medical, and research applications.
The production procedure of ampicillin includes the fermentation of Penicillium chrysogenum to produce penicillin G, which is further chemically modified. One of the major steps in the procedure is the acylation of 6-aminopenicillanic acid (6-APA), which is derived from penicillin G, with D-(-)- phenylglycine chloride hydrochloride. This procedure then yield ampicillin which is further purified and formulated into numerous pharmaceutical preparations. The production procedure is monitored under stringent quality control measures to safeguard the purity and potency of the antibiotic.
| Key Attributes | Details |
|---|---|
| Product Name | Ampicillin |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ampicillin Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.